{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:42:50Z","timestamp":1697478170110},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1006\/gyno.2001.6349","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"109-114","source":"Crossref","is-referenced-by-count":4,"title":["Survival of BRCA1 Negative Ovarian Cancer Patients Based on Family History"],"prefix":"10.1006","volume":"83","author":[{"given":"Christina S.","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6349_RF1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ssu.2980100403","article-title":"Etiology, biology, and epidemiology of ovarian cancer","volume":"10","author":"Baker","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"10.1006\/gyno.2001.6349_RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8545(21)00304-1","article-title":"Epidemiology and screening of ovarian cancer","volume":"21","author":"Tortolero-Luna","year":"1994","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1006\/gyno.2001.6349_RF3","series-title":"Ovarian cancer","first-page":"189","article-title":"Hereditary ovarian cancer","author":"Lynch","year":"1993"},{"key":"10.1006\/gyno.2001.6349_RF4","first-page":"521","article-title":"Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast\/ovarian cancer relationship","volume":"45","author":"Schildkraut","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1006\/gyno.2001.6349_RF5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1469-1809.1991.tb00856.x","article-title":"Genetic epidemiology of ovarian cancer: segregation analysis","volume":"55","author":"Houlston","year":"1991","journal-title":"Ann Hum Genet"},{"key":"10.1006\/gyno.2001.6349_RF6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","article-title":"Hereditary ovarian cancer: a clinicopathological study","volume":"11","author":"Bewtra","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.2001.6349_RF7","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z","article-title":"Hereditary and familial ovarian cancer in Southern Ontario","volume":"74","author":"Narod","year":"1994","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6349_RF8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cncr.2820710214","article-title":"Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981\u20131991","volume":"71","author":"Piver","year":"1993","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6349_RF10","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(197804)41:4<1543::AID-CNCR2820410444>3.0.CO;2-Y","article-title":"Familial association of breast\/ovarian carcinoma","volume":"41","author":"Lynch","year":"1978","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6349_RF11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/ob.1996.v175.a74288","article-title":"Role of BRCA1 mutation screening in the management of familial ovarian cancer","volume":"175","author":"Berchuck","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6349_RF12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1006\/gyno.2001.6349_RF13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nm0797-721","article-title":"Double indemnity: p53, BRCA and cancer","volume":"3","author":"Brugarolas","year":"1997","journal-title":"Nat Med"},{"key":"10.1006\/gyno.2001.6349_RF14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0092-8674(00)80936-8","article-title":"BRCA1, BRCA2, and DNA damage response","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1006\/gyno.2001.6349_RF15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/382678a0","article-title":"Transcriptional activation by BRCA1","volume":"382","author":"Chapman","year":"1996","journal-title":"Nature"},{"key":"10.1006\/gyno.2001.6349_RF16","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1073\/pnas.93.24.13595","article-title":"Evidence for a transcriptional activation function of BRCA1 C-terminal region","volume":"93","author":"Monteiro","year":"1996","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"10.1006\/gyno.2001.6349_RF17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/386772a0","article-title":"Transcriptional activation functions in BRCA2","volume":"386","author":"Milner","year":"1997","journal-title":"Nature"},{"key":"10.1006\/gyno.2001.6349_RF18","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1073\/pnas.94.11.5605","article-title":"BRCA1 is a component of the RNA polymerase II holoenzyme","volume":"194","author":"Scully","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2001.6349_RF19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1126\/science.281.5379.1009","article-title":"BRCA1 required for transcription-coupled repair of oxidative DNA damage","volume":"281","author":"Gowen","year":"1998","journal-title":"Science"},{"key":"10.1006\/gyno.2001.6349_RF20","first-page":"2998","article-title":"Mutation analysis of the BRCA1 gene in ovarian cancers","volume":"55","author":"Takahashi","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2001.6349_RF21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/oxfordjournals.aje.a114994","article-title":"Familial ovarian cancer: a population based case-control study","volume":"128","author":"Schildkraut","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1006\/gyno.2001.6349_RF22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/oxfordjournals.annonc.a059053","article-title":"A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome","volume":"6","author":"Chang","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1006\/gyno.2001.6349_RF23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/gyno.1993.1265","article-title":"Familial ovarian cancer","volume":"51","author":"Buller","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6349_RF24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden","volume":"16","author":"Johannsson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6349_RF26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6349_RF27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2307\/2530299","article-title":"Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint","volume":"38","author":"Schoenfeld","year":"1982","journal-title":"Biometrics"},{"key":"10.1006\/gyno.2001.6349_RF28","first-page":"1255","article-title":"BRCA1 mutations and survival in women with ovarian cancer","volume":"336","author":"Johannson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF29","first-page":"1256","article-title":"BRCA1 mutations and survival in women with ovarian cancer","volume":"336","author":"Brunet","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF30","first-page":"1255","article-title":"BRCA1 mutations and survival in women with ovarian cancer","volume":"336","author":"Modan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM199704243361713","article-title":"BRCA1 mutations and survival in women with ovarian cancer","volume":"336","author":"Cannistra","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF32","first-page":"1255","article-title":"BRCA1 mutations and survival in women with ovarian cancer","volume":"336","author":"Burk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF33","first-page":"1254","article-title":"BRCA1 mutations and survival in women with ovarian cancer","author":"Whitmore","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6349_RF34","first-page":"868","article-title":"Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"59","author":"Pharoah","year":"1999","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2001.6349_RF35","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"10.1006\/gyno.2001.6349_RF36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(98)04119-1","article-title":"ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer","volume":"352","author":"The ICON","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/gyno.2001.6349_RF37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1086\/302583","article-title":"The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes","volume":"65","author":"Gayther","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1006\/gyno.2001.6349_RF38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.2000.5816","article-title":"The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer","volume":"77","author":"van Nagell","year":"2000","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801963498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801963498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T22:13:30Z","timestamp":1680560010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801963498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0090825801963498"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6349","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}